We are live on !
Find out more
Bleichroeder Portfolio holdings
AUM
$1.02B
Turnover
33.63%
1-Year Est. Return
33%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
(-12%)
Cap. Flow
+$3.41M
Cap. Flow % of AUM
Cap. Flow %
0.61%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GPGI
GPGI
|
+$11M |
| 2 |
CTIC
CTI BioPharma
CTIC
|
+$10.8M |
| 3 |
Brunswick
BC
|
+$5.76M |
| 4 |
Televisa
TV
|
+$5.18M |
| 5 |
Duos Technologies
DUOT
|
+$4.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$32.8M |
| 2 |
GBT
Global Blood Therapeutics
GBT
|
+$3.66M |
| 3 |
IHC
Independence Holding
IHC
|
+$3.1M |
| 4 |
Enterprise Products Partners
EPD
|
+$2.77M |
| 5 |
TLMD
SOC Telemed
TLMD
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.74% |
| 2 | Miscellaneous | 15.57% |
| 3 | Industrials | 15.14% |
| 4 | Financials | 14.94% |
| 5 | Materials | 10.92% |
Similar funds
SW
Bleichroeder's Q1 2022 Portfolio in Review
As of Q1 2022, Bleichroeder held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Bleichroeder's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.
- Bleichroeder's largest Q1 2022 buy was GPGI: 1,776,008 shares worth $11.2M.
- Bleichroeder added most to CTI BioPharma in Q1 2022, an estimated $10.8M increase.
- Bleichroeder's biggest Q1 2022 reduction was Tricida, cutting an estimated $1.53M.
- Bleichroeder fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
- Bleichroeder's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
- Bleichroeder opened 20 new positions and closed 12 in Q1 2022.
- Bleichroeder's portfolio value fell 12% quarter-over-quarter to $563M.
Based on Bleichroeder's 13F filing for Q1 2022, filed 11 May 2022.